Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer Via Upregulation of SLC7A11

Overview

Journal Cancer Res

Specialty Oncology

Date 2021 Aug 13

PMID 34385181

Citations 92

Authors

Xinbo Wang

Yueqing Chen

Xudong Wang

Hongling Tian

Yanjin Wang

Jiali Jin

Zezhi Shan

Yue Liu

Zhenyu Cai

Xinyuan Tong

Yi Luan

Xiao Tan

Bing Luan

Xin Ge

Hongbin Ji

Xuejun Jiang

Ping Wang

Affiliations

Soon will be listed here.

Abstract

Ferroptosis is a lipid peroxidation-dependent cell death caused by metabolic dysfunction. Ferroptosis-associated enzymes are promising therapeutic targets for cancer treatment. However, such therapeutic strategies show limited efficacy due to drug resistance and other largely unknown underlying mechanisms. Here we report that cystine transporter SLC7A11 is upregulated in lung cancer stem-like cells (CSLC) and can be activated by stem cell transcriptional factor SOX2. Mutation of SOX2 binding site in promoter reduced SLC7A11 expression and increased sensitivity to ferroptosis in cancer cells. Oxidation at Cys265 of SOX2 inhibited its activity and decreased the self-renewal capacity of CSLCs. Moreover, tumors with high SOX2 expression were more resistant to ferroptosis, and SLC7A11 expression was positively correlated with SOX2 in both mouse and human lung cancer tissue. Together, our study provides a mechanism by which cancer cells evade ferroptosis and suggests that oxidation of SOX2 can be a potential therapeutic target for cancer treatment. SIGNIFICANCE: This study uncovers a SOX2-SLC7A11 regulatory axis that confers resistance to ferroptosis in lung cancer stem-like cells.

Citing Articles

Role of environmental pollutants-induced ferroptosis in pulmonary diseases.

Yang L, Qiao Y, Huang Z, Chen Y, Zhang E, Liu Z Front Med (Lausanne). 2025; 12:1542275.

PMID: 40066170 PMC: 11891068. DOI: 10.3389/fmed.2025.1542275.

Eupatilin mitigates ICH-induced brain injury via SOX2/SLC7A11 regulation of ferroptosis.

Shen Y, Wang Y, Liu F Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40047856 DOI: 10.1007/s00210-025-03928-z.

The molecular and metabolic landscape of ferroptosis in respiratory diseases: Pharmacological aspects.

Wu T, Ji M, Li T, Luo L J Pharm Anal. 2025; 15(1):101050.

PMID: 40034685 PMC: 11873008. DOI: 10.1016/j.jpha.2024.101050.

Targeting AKT as a promising strategy for SOX2-positive, chemoresistant osteosarcoma.

Liu Y, Kang L, Luo J, Yang M, Wang D, Ye J Bone Res. 2025; 13(1):25.

PMID: 39994220 PMC: 11850766. DOI: 10.1038/s41413-024-00395-9.

FBF1 maintains stem cell-like properties in breast cancer via PI3K/AKT/SOX2 axis.

Guo C, Li S, Liu J, Ma Y, Liang A, Lou Y Stem Cell Res Ther. 2025; 16(1):83.

PMID: 39988656 PMC: 11849350. DOI: 10.1186/s13287-025-04194-9.

References

Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin S . The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 2020; 30(2):146-162. PMC: 7015061. DOI: 10.1038/s41422-019-0263-3. View

Green D . The Coming Decade of Cell Death Research: Five Riddles. Cell. 2019; 177(5):1094-1107. PMC: 6534278. DOI: 10.1016/j.cell.2019.04.024. View

Majumder S, Crabtree J, Golde T, Minter L, Osborne B, Miele L . Targeting Notch in oncology: the path forward. Nat Rev Drug Discov. 2020; 20(2):125-144. DOI: 10.1038/s41573-020-00091-3. View

Gu Y, Albuquerque C, Braas D, Zhang W, Villa G, Bi J . mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT. Mol Cell. 2017; 67(1):128-138.e7. PMC: 5521991. DOI: 10.1016/j.molcel.2017.05.030. View

Lang X, Green M, Wang W, Yu J, Choi J, Jiang L . Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11. Cancer Discov. 2019; 9(12):1673-1685. PMC: 6891128. DOI: 10.1158/2159-8290.CD-19-0338. View

Tsoi J, Robert L, Paraiso K, Galvan C, Sheu K, Lay J . Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress. Cancer Cell. 2018; 33(5):890-904.e5. PMC: 5953834. DOI: 10.1016/j.ccell.2018.03.017. View

Liang M, Ma J, Chen L, Kozlowski P, Qin W, Li D . TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity. Oncogene. 2009; 29(11):1588-97. PMC: 2841700. DOI: 10.1038/onc.2009.452. View

Wu J, Minikes A, Gao M, Bian H, Li Y, Stockwell B . Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. 2019; 572(7769):402-406. PMC: 6697195. DOI: 10.1038/s41586-019-1426-6. View

Jiang L, Kon N, Li T, Wang S, Su T, Hibshoosh H . Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015; 520(7545):57-62. PMC: 4455927. DOI: 10.1038/nature14344. View

10.

Hsieh M, Choe J, Gadhvi J, Kim Y, Arguez M, Palmer M . p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas. Cell Rep. 2019; 28(7):1860-1878.e9. PMC: 7048935. DOI: 10.1016/j.celrep.2019.07.027. View

11.

Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J . Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020; 5(1):8. PMC: 7005297. DOI: 10.1038/s41392-020-0110-5. View

12.

Koppula P, Zhang Y, Zhuang L, Gan B . Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond). 2018; 38(1):12. PMC: 5993148. DOI: 10.1186/s40880-018-0288-x. View

13.

Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P . BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018; 20(10):1181-1192. PMC: 6170713. DOI: 10.1038/s41556-018-0178-0. View

14.

Wang Z, Kang L, Zhang H, Huang Y, Fang L, Li M . AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation. Oncogene. 2019; 38(26):5250-5264. DOI: 10.1038/s41388-019-0790-x. View

15.

Li H, Ning S, Ghandi M, Kryukov G, Gopal S, Deik A . The landscape of cancer cell line metabolism. Nat Med. 2019; 25(5):850-860. PMC: 6629041. DOI: 10.1038/s41591-019-0404-8. View

16.

Ubellacker J, Tasdogan A, Ramesh V, Shen B, Mitchell E, Martin-Sandoval M . Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 2020; 585(7823):113-118. PMC: 7484468. DOI: 10.1038/s41586-020-2623-z. View

17.

Torti S, Manz D, Paul B, Blanchette-Farra N, Torti F . Iron and Cancer. Annu Rev Nutr. 2018; 38:97-125. PMC: 8118195. DOI: 10.1146/annurev-nutr-082117-051732. View

18.

Kang Y, Mockabee-Macias A, Jiang C, Falzone A, Prieto-Farigua N, Stone E . Non-canonical Glutamate-Cysteine Ligase Activity Protects against Ferroptosis. Cell Metab. 2020; 33(1):174-189.e7. PMC: 7839835. DOI: 10.1016/j.cmet.2020.12.007. View

19.

Gao Y, Zhang W, Han X, Li F, Wang X, Wang R . YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression. Nat Commun. 2014; 5:4629. DOI: 10.1038/ncomms5629. View

20.

Koren E, Fuchs Y . Modes of Regulated Cell Death in Cancer. Cancer Discov. 2021; 11(2):245-265. DOI: 10.1158/2159-8290.CD-20-0789. View